Human Health Holdings Limited (HKG:1419)
Hong Kong · Delayed Price · Currency is HKD 0.7650
+0.0050 (0.66%)
Oct 14, 2026, 3:50 PM HKT
Human Health Holdings Income Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 671.67 | 644.43 | 590.82 | 1,002 | 1,122 | |
Revenue Growth | 4.23% | 9.07% | -41.02% | -10.70% | 71.34% |
Cost of Revenue | 360.32 | 348.97 | 320.97 | 408.51 | 462.11 |
Gross Profit | 311.34 | 295.46 | 269.85 | 593.24 | 659.69 |
Selling, General & Admin | 205.35 | 197.7 | 184.47 | 211.18 | 166.7 |
Amortization of Goodwill & Intangibles | 1.18 | 1.49 | 1.61 | 1.61 | 1.61 |
Operating Expenses | 272.08 | 265.17 | 251.7 | 286.16 | 230.88 |
Operating Income | 39.27 | 30.29 | 18.15 | 307.07 | 428.81 |
Interest Expense | -6.5 | -6.55 | -8.22 | -8.3 | -2.93 |
Interest & Investment Income | 7.9 | 12.7 | 16.61 | 8.49 | 0.2 |
Earnings From Equity Investments | 0.2 | -0.24 | -1.27 | -1.54 | -1.98 |
Other Non Operating Income (Expenses) | 2.79 | 1.96 | 1.88 | 2.51 | 0.82 |
EBT Excluding Unusual Items | 43.66 | 38.16 | 27.15 | 308.23 | 424.92 |
Gain (Loss) on Sale of Investments | -9.4 | 2.28 | 16.58 | -6.27 | 25.52 |
Asset Writedown | -3.11 | -10.5 | -17.16 | -63.15 | -10 |
Other Unusual Items | - | - | - | - | 4.82 |
Pretax Income | 31.15 | 29.94 | 26.56 | 238.82 | 445.26 |
Income Tax Expense | 2.81 | 3.31 | 2.38 | 57.98 | 69.95 |
Earnings From Continuing Operations | 28.35 | 26.63 | 24.19 | 180.84 | 375.31 |
Minority Interest in Earnings | -1.22 | -0.3 | - | - | - |
Net Income | 27.13 | 26.34 | 24.19 | 180.84 | 375.31 |
Net Income to Common | 27.13 | 26.34 | 24.19 | 180.84 | 375.31 |
Net Income Growth | 3.00% | 8.88% | -86.62% | -51.82% | 159.81% |
Shares Outstanding (Basic) | 380 | 380 | 380 | 380 | 380 |
Shares Outstanding (Diluted) | 380 | 380 | 380 | 380 | 380 |
Shares Change | - | - | - | - | - |
EPS (Basic) | 0.07 | 0.07 | 0.06 | 0.48 | 0.99 |
EPS (Diluted) | 0.07 | 0.07 | 0.06 | 0.48 | 0.99 |
EPS Growth | 2.90% | 8.27% | -86.61% | -51.86% | 159.81% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | - | 90.83 | -26.3 | 580.24 | 219.3 |
Free Cash Flow Per Share | - | 0.24 | -0.07 | 1.53 | 0.58 |
Dividend Per Share | 0.031 | 0.030 | 0.028 | 0.160 | 0.300 |
Dividend Growth | 3.33% | 7.14% | -82.50% | -46.67% | 150.00% |
Gross Margin | 46.35% | 45.85% | 45.67% | 59.22% | 58.81% |
Operating Margin | 5.85% | 4.70% | 3.07% | 30.65% | 38.22% |
Profit Margin | 4.04% | 4.09% | 4.09% | 18.05% | 33.46% |
Free Cash Flow Margin | - | 14.09% | -4.45% | 57.92% | 19.55% |
EBITDA | 59.6 | 50.62 | 39.07 | 323.46 | 437.63 |
EBITDA Margin | 8.87% | 7.85% | 6.61% | 32.29% | 39.01% |
D&A For EBITDA | 20.34 | 20.34 | 20.92 | 16.39 | 8.83 |
EBIT | 39.27 | 30.29 | 18.15 | 307.07 | 428.81 |
EBIT Margin | 5.85% | 4.70% | 3.07% | 30.65% | 38.22% |
Effective Tax Rate | 9.01% | 11.05% | 8.94% | 24.28% | 15.71% |